| Dr Victor E Mendoza, MD | |
|
5130 Cyrus Cir, Birmingham, AL 35242-4630 | |
| (205) 981-0414 | |
| Not Available |
| Full Name | Dr Victor E Mendoza |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 25 Years |
| Location | 5130 Cyrus Cir, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003831454 | NPI | - | NPPES |
| Entity Name | Dark Side Medical, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609153030 PECOS PAC ID: 4284809773 Enrollment ID: O20111212000705 |
News Archive
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.
AmeriHealth New Jersey has entered a two-year contract extension with University Medical Group.
A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania. The trial, which is expected to involve up to 16,000 children, is on schedule, with more than 5,000 children already enrolled, researchers announced Tuesday at the 5th Multilateral Initiative on Malaria Pan-African Malaria Conference.
High blood pressure may put women at greater risk for dementia later in life by increasing white matter abnormalities in the brain, report researchers from the University of Pittsburgh Graduate School of Public Health in a study published online in the Journal of Clinical Hypertension.
› Verified 6 days ago
| Entity Name | Wellness And Weight Loss |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073882700 PECOS PAC ID: 7416291125 Enrollment ID: O20181206003300 |
News Archive
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.
AmeriHealth New Jersey has entered a two-year contract extension with University Medical Group.
A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania. The trial, which is expected to involve up to 16,000 children, is on schedule, with more than 5,000 children already enrolled, researchers announced Tuesday at the 5th Multilateral Initiative on Malaria Pan-African Malaria Conference.
High blood pressure may put women at greater risk for dementia later in life by increasing white matter abnormalities in the brain, report researchers from the University of Pittsburgh Graduate School of Public Health in a study published online in the Journal of Clinical Hypertension.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victor E Mendoza, MD 5130 Cyrus Cir, Birmingham, AL 35242-4630 Ph: (205) 981-0414 | Dr Victor E Mendoza, MD 5130 Cyrus Cir, Birmingham, AL 35242-4630 Ph: (205) 981-0414 |
News Archive
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.
AmeriHealth New Jersey has entered a two-year contract extension with University Medical Group.
A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania. The trial, which is expected to involve up to 16,000 children, is on schedule, with more than 5,000 children already enrolled, researchers announced Tuesday at the 5th Multilateral Initiative on Malaria Pan-African Malaria Conference.
High blood pressure may put women at greater risk for dementia later in life by increasing white matter abnormalities in the brain, report researchers from the University of Pittsburgh Graduate School of Public Health in a study published online in the Journal of Clinical Hypertension.
› Verified 6 days ago
Dr. Kenneth G Varley, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Hugh Daniel Dr Ste 360, Birmingham, AL 35242 Phone: 205-995-9967 Fax: 205-995-0635 | |
Dr. Michael Scott Kendrick, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1020 26th St S, Suite 100, Birmingham, AL 35205 Phone: 205-332-3155 Fax: 205-332-3162 | |
Dr. James Gillespie, M.B.B.S. Pain Medicine Medicare: Medicare Enrolled Practice Location: 1020 26th St S # 100, Birmingham, AL 35205 Phone: 205-332-3155 | |
Dr. Sandra Lynne Durham, M.D. Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 6801 Cahaba Valley Rd, Ste 208, Birmingham, AL 35242 Phone: 205-222-7651 | |
Brandon Schyler Brooks, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 Fax: 205-930-8985 |